At two o'clock that afternoon, Celeste Sterling called to order the extraordinary shareholder meeting of Sterling Bio-Tech in the company's Midtown headquarters. The boardroom was packed with institutional investors, medical researchers, and corporate governance advocates. Celeste stood at the head of the long table, dressed in a tailored navy blazer, her expression regal and confident. "Ladies and gentlemen," Celeste began, "today marks the rebirth of Sterling Bio-Tech as an enterprise…
Keep reading in the app
This chapter is in the Booknovel app. Unlock it with coins, a short ad, the free timer or VIP.
Scan with your phone camera
Opens chapter 75 directly. New readers get free coins.